SKAN Group AG (LTS:0SKN) Gross-Profit-to-Asset % : 66.75% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is SKAN Group AG Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. SKAN Group AG's annualized Gross Profit for the quarter that ended in Dec. 2023 was CHF257.2 Mil. SKAN Group AG's average Total Assets over the quarter that ended in Dec. 2023 was CHF385.3 Mil. Therefore, SKAN Group AG's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 66.75%.

SKAN Group AG Gross-Profit-to-Asset % Historical Data

The historical data trend for SKAN Group AG's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SKAN Group AG Gross-Profit-to-Asset % Chart

SKAN Group AG Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Gross-Profit-to-Asset %

51.25

57.52

55.67

63.16

SKAN Group AG Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial			54.85	51.32	58.34	57.01	66.75

Competitive Comparison of SKAN Group AG's Gross-Profit-to-Asset %

For the Medical Instruments & Supplies subindustry, SKAN Group AG's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SKAN Group AG's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SKAN Group AG's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where SKAN Group AG's Gross-Profit-to-Asset % falls into.

SKAN Group AG Gross-Profit-to-Asset % Calculation

SKAN Group AG's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2023 )	/	( (Total Assets (A: Dec. 2022 )	+	Total Assets (A: Dec. 2023 ))	/ count )
	=	240.564	/	( (388.351	+	373.449)	/ 2 )
	=	240.564	/	380.9
	=	63.16 %

SKAN Group AG's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	257.196	/	( (397.23	+	373.449)	/ 2 )
	=	257.196	/	385.3395
	=	66.75 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

SKAN Group AG Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of SKAN Group AG's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

SKAN Group AG (LTS:0SKN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SKAN Group AG (LTS:0SKN) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

SKANz:UK SKAN:Switzerland

Address

Kreuzstrasse 5, Allschwil, CHE, 4123

Website

https://www.skan.com

SKAN Group AG is a global market and technological company for isolators, cleanroom devices, and decontamination processes for the aseptic production of biopharmaceutical substances. Its core competency is the design and development of process isolators for the aseptic filling of biopharmaceutical products. The company offer its customers process support, services, and consumables. Its products include biological indicators, isolators, Laboratory/cleanroom equipment, laminar flow, safety workbench, and transfer system.

SKAN Group AG (LTS:0SKN) Headlines

No Headlines